Position
Chief Financial Officer
Company
Hansa Biopharma
LundBiotechnologyHealth CareMedicalTherapeuticsBiopharmaDescription
Hansa Biopharma announces the appointment of Evan Ballantyne as Chief Financial Officer (CFO), effective 1 March 2024.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Aculys Pharma Appoints Hidemasa Tanigaki as Chief Executive Officer and Representative Director (April 1, 2024)
- Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer (February 21, 2024)
- Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer (February 21, 2024)
- AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer (February 20, 2024)
- Diakonos Oncology Appoints Biotech Veteran Anthony Baldor as Chief Financial Officer (February 26, 2024)
- Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer (February 26, 2024)
Who to call at Hansa Biopharma, and when
A new leader at Hansa Biopharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Hansa Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Hansa Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Hansa Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Hansa Biopharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Hansa Biopharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.